首页> 美国卫生研究院文献>Infection and Immunity >CCL20/Macrophage Inflammatory Protein 3α and Tumor Necrosis Factor Alpha Production by Primary Uterine Epithelial Cells in Response to Treatment with Lipopolysaccharide or Pam3Cys
【2h】

CCL20/Macrophage Inflammatory Protein 3α and Tumor Necrosis Factor Alpha Production by Primary Uterine Epithelial Cells in Response to Treatment with Lipopolysaccharide or Pam3Cys

机译:脂多糖或Pam3Cys处理后原代子宫上皮细胞产生CCL20 /巨噬细胞炎性蛋白3α和肿瘤坏死因子α

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Having previously shown that CCL20/macrophage inflammatory protein 3α and tumor necrosis factor alpha (TNF-α) are released by polarized primary rat uterine epithelial cells (UEC) in response to Escherichia coli but not to Lactobacillus rhamnosus, we sought to determine if epithelial cells are responsive to pathogen-associated molecular patterns (PAMP), including lipopolysaccharide (LPS), lipoteichoic acid (LTA), and Pam3Cys, a bacterial lipoprotein analog. Epithelial cells were grown to confluence on Nunc cell culture inserts prior to apical treatment with PAMPs. In response to LPS, LTA, and Pam3Cys (EMC Microcollection GmbH, Tübingen, Germany), CCL20 levels increased (4- to 10-fold) while PAMPs caused increased TNF-α (1- to 4-fold) in the medium collected after 24 h of incubation. Both apical and basolateral secretion of CCL20 and TNF-α increased in response to PAMPs, but treatments had no effect on cell viability and integrity, as measured by transepithelial resistance. Time course studies of CCL20 and TNF-α release in response to Pam3Cys and LPS indicated that CCL20 release peaked between 2 and 4 h after treatment, whereas TNF-α release was gradual over the length of the incubation. Freeze-thaw and cell lysis experiments, along with actinomycin D studies, suggested that CCL20 and TNF-α are synthesized in response to PAMP stimulation. Taken together, these studies demonstrate that E. coli and selected PAMPs have direct effects on the production of CCL20 and TNF-α without affecting cell integrity. Since CCL20 is known to be both chemotactic and antimicrobial, the increase in apical and basolateral release by UEC in response to PAMPs suggests a new mechanism of innate immune protection in the female reproductive tract.
机译:先前已显示极化的原代大鼠子宫上皮细胞(UEC)响应大肠杆菌而不是鼠李糖乳杆菌释放了CCL20 /巨噬细胞炎性蛋白3α和肿瘤坏死因子α(TNF-α),我们试图确定是否上皮细胞它们对病原体相关分子模式(PAMP)敏感,包括脂多糖(LPS),脂蛋白酸(LTA)和细菌脂蛋白类似物Pam3Cys。在用PAMP进行根尖处理之前,使上皮细胞生长到Nunc细胞培养插入物上。为了响应LPS,LTA和Pam3Cys(德国蒂宾根市的EMC Microcollection GmbH),CCL20水平升高(4至10倍),而PAMPs导致在收集后的培养基中TNF-α升高(1至4倍)。孵育24小时。响应PAMPs,CCL20和TNF-α的根尖和基底外侧分泌均增加,但经跨上皮耐药性测定,治疗对细胞活力和完整性无影响。对Pam3Cys和LPS响应的CCL20和TNF-α释放的时程研究表明,治疗后CCL20释放在2至4 h达到峰值,而TNF-α的释放在整个培养过程中是逐渐的。冻融和细胞裂解实验以及放线菌素D研究表明,CCL20和TNF-α是响应PAMP刺激而合成的。综上所述,这些研究表明,大肠杆菌和选定的PAMP对CCL20和TNF-α的产生具有直接影响,而不会影响细胞完整性。由于已知CCL20既具有趋化性又具有抗菌性,因此UEC响应PAMPs引起的根尖和基底外侧释放的增加提示了女性生殖道固有免疫保护的新机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号